These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12058386)

  • 21. In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi.
    González GM
    Med Mycol; 2009 Feb; 47(1):71-6. PubMed ID: 19101837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging fungal pathogens.
    Anaissie EJ; Bodey GP; Rinaldi MG
    Eur J Clin Microbiol Infect Dis; 1989 Apr; 8(4):323-30. PubMed ID: 2497012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The new fungal opportunists are coming.
    Perfect JR; Schell WA
    Clin Infect Dis; 1996 May; 22 Suppl 2():S112-8. PubMed ID: 8722837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [State of the art in invasive diseases by filamentous fungi].
    Pemán J; Quindós G
    Rev Iberoam Micol; 2014; 31(4):213-8. PubMed ID: 25449676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fungal infections in children with malignant disease].
    Michel G
    Arch Pediatr; 2011 May; 18 Suppl 1():S3-7. PubMed ID: 21596284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fungal infections in iatrogenically compromised hosts.
    Rex JH; Walsh TJ; Anaissie EJ
    Adv Intern Med; 1998; 43():321-71. PubMed ID: 9506187
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection of the 'Big Five' mold killers of humans: Aspergillus, Fusarium, Lomentospora, Scedosporium and Mucormycetes.
    Thornton CR
    Adv Appl Microbiol; 2020; 110():1-61. PubMed ID: 32386603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of internal and outdoor factors on filamentous fungal flora in hematology wards.
    Brenier-Pinchart MP; Lebeau B; Quesada JL; Mallaret MR; Borel JL; Mollard A; Garban F; Brion JP; Molina L; Bosson JL; Cahn JY; Grillot R; Pelloux H
    Am J Infect Control; 2009 Oct; 37(8):631-7. PubMed ID: 19631408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive mycoses following trauma.
    Hajdu S; Obradovic A; Presterl E; Vécsei V
    Injury; 2009 May; 40(5):548-54. PubMed ID: 18656189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pocket guide to invasive mycoses in onco-hematologic patients].
    Bermúdez A; Carreras E; De la Cámara R; Eraso E; Fortún J; García-Ruiz JC; Guarro J; Jarque I; Marcos de Lucas E; Mayayo E; Pastor FJ; Pemán J; Pontón J; Quindós G; Salavert M; Sanz MA; Zaragoza R
    Rev Iberoam Micol; 2009; Suppl():3-199. PubMed ID: 20143497
    [No Abstract]   [Full Text] [Related]  

  • 31. The spectrum of non-Candida fungal infections following bone marrow transplantation.
    Morrison VA; Haake RJ; Weisdorf DJ
    Medicine (Baltimore); 1993 Mar; 72(2):78-89. PubMed ID: 8479326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention.
    Suleyman G; Alangaden GJ
    Infect Dis Clin North Am; 2021 Dec; 35(4):1027-1053. PubMed ID: 34752219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient: case report and review of the literature.
    Salmon A; Debourgogne A; Vasbien M; Clément L; Collomb J; Plénat F; Bordigoni P; Machouart M
    Clin Microbiol Infect; 2010 May; 16(5):508-12. PubMed ID: 19624505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.
    Pfaller MA; Diekema DJ
    J Clin Microbiol; 2004 Oct; 42(10):4419-31. PubMed ID: 15472288
    [No Abstract]   [Full Text] [Related]  

  • 35. [General epidemiology of invasive fungal disease].
    Pemán J; Salavert M
    Enferm Infecc Microbiol Clin; 2012 Feb; 30(2):90-8. PubMed ID: 22079232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recommendations of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the prevention of invasive fungal infection due to filamentous fungi].
    Ruiz-Camps I; Aguado JM; Almirante B; Bouza E; Ferrer Barbera C; Len O; López-Cerero L; Rodríguez-Tudela JL; Ruiz M; Solé A; Vallejo C; Vázquez L; Zaragoza R; Cuenca-Estrella M;
    Enferm Infecc Microbiol Clin; 2010 Mar; 28(3):172.e1-172.e21. PubMed ID: 20202721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of invasive mycoses in North America.
    Pfaller MA; Diekema DJ
    Crit Rev Microbiol; 2010; 36(1):1-53. PubMed ID: 20088682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of fungal and other opportunistic infections in immunocompromised patients.
    Wade JC
    Leukemia; 1997 May; 11 Suppl 4():S38-9. PubMed ID: 9179282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevention and control of nosocomial and health-care facilities associated infections caused by species of Candida and other yeasts].
    Pemán J; Zaragoza R; Salavert M
    Rev Esp Quimioter; 2013 Dec; 26(4):298-311. PubMed ID: 24399344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Invasive fungal disease in patients from five hospitals in the Valparaíso region, Chile: 2004 to 2009].
    Cruz Ch R; Piontelli L E
    Rev Chilena Infectol; 2011 Apr; 28(2):123-9. PubMed ID: 21720691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.